Skip to content

Medline, Inc. MDLN Medline Brand — Net Sales

Other segment segments

Supply Chain Solutions
$3.89B+15.0%

Similar metrics at other companies

Boston Scientific logo
BSXMedSurg — Net Sales
$1.7B+7.9%
Solventum logo
SOLVMedSurg — Total Net Sales
$1.23B+6.7%
AngioDynamics logo
ANGOMed Device — Net Sales
$41.14M+1.2%
Boston Scientific logo
BSXMedSurg — Net sales of reportable segments
$1.7B+5.7%
Medtronic logo
MDTMedical Surgical — Net Sales
$2.39B+8.0%
AngioDynamics logo
ANGOMed Tech — Net Sales
$37.28M+19.0%

Other financials

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B
Total equity$11.3B
Total assets$39.0B

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation

See full
Market cap$32.87B+5.7%
Enterprise value$43.19B
P/E39.1×
P/S1.2×

Profitability

See full
Gross margin27.4%+1.5pp
Operating margin8.5%+2.3pp
Net margin4.6%+2.7pp
FCF margin6.4%+0.5pp

Returns & leverage

See full
Return on equity7.7%
Debt / equity1.1×
Current ratio4.4×

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's medline brand — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medline, Inc. 's medline brand — net sales?
Medline, Inc. (MDLN) reported medline brand — net sales of $3.47B in Q1 2026.
How has Medline, Inc. 's medline brand — net sales changed year-over-year?
Medline, Inc. 's medline brand — net sales increased by 6.2% year-over-year, from $3.26B to $3.47B.
What does medline brand — net sales mean?
Represents the total revenue generated by the Medline Brand segment from the sale of surgical solutions, front line care products, and laboratory diagnostics after accounting for returns, allowances, and discounts. This is the primary indicator of market demand and the segment's ability to capture share in the medical-surgical supply market. It reflects the core top-line performance of the manufacturing and procurement operations.